Edition:
United Kingdom

Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

304.40GBp
16 Aug 2019
Change (% chg)

1.10 (+0.36%)
Prev Close
303.30
Open
307.70
Day's High
307.70
Day's Low
297.70
Volume
838,690
Avg. Vol
1,031,486
52-wk High
506.80
52-wk Low
288.30

Summary

Name Age Since Current Position

Edwin Hertzog

69 2016 Non-Executive Chairman of the Board

Ronnie van der Merwe

55 2018 Chief Executive Officer, Executive Director

Jurgens Myburgh

2016 Group Chief Financial Officer, Executive Director

David Hadley

Chief Executive Officer - Mediclinic Middle East

Daniel Liedtke

2019 Chief Executive Officer: Hirslanden

Koert Pretorius

55 Chief Executive Officer of Mediclinic Southern Africa

Magnus Oetiker

2018 Chief Human Resource Officer

Dirk Le Roux

2016 Chief Information Officer

Gert Hattingh

52 2016 Chief Corporate Services Officer

Rene Toua

2018 Chief Clinical Officer

Jannie Durand

51 2016 Non-Executive Director

Danie Meintjes

62 2018 Non-Executive Director

Trevor Petersen

2019 Non-Executive Director

Muhadditha Al Hashimi

2017 Independent Non-Executive Director

James Grieve

67 2019 Senior Non-Executive Independent Director

Felicity Harvey

2017 Independent Non-Executive Director

Seamus Declan Keating

54 2016 Independent Non-Executive Director

Anja Oswald

2018 Independent Non-Executive Director

Tom Singer

2019 Non-Executive Independent Director

James Arnold

2016 Head of Investor Relations

Biographies

Name Description

Edwin Hertzog

Dr. Edwin (Edwin) Hertzog, Ph.D., is no longer a Non-Executive Chairman of the Board of Mediclinic International Plc., effective July 2020. Prior to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in 2016, he served as a director of Mediclinic International Limited from 1983 and as the Chairman from 1992. As a specialist anaesthetist, he was commissioned by the then Rembrandt group (now Remgro) in 1983 to undertake a feasibility study on the establishment of a private hospital group, and three years later, in 1986, Mediclinic International Limited (then Medi-Clinic Corporation Limited) was listed on the JSE. He was appointed as the first managing director of Mediclinic International Limited upon its establishment in 1983. He served as executive Chairman of Mediclinic from 1992 until August 2012 when he retired from his executive role, but remained on the Board as non-executive Chairman. He also serves as the non-executive deputy Chairman of Remgro and is a past Chairman of the council of the Stellenbosch University. Qualifications: Dr Hertzog holds a Bachelor of Medicine and Bachelor of Surgery (MB, ChB); Fellowship of the Faculty of Anaesthesiologists (SA); and a Doctor of Philosophy (Ph.D) (honoris causa).

Ronnie van der Merwe

Dr. Ronnie Van der Merwe is Chief Executive Officer, Executive Director of the Company., effective August 1, 2018. He is a specialist anaesthetist who worked in the medical insurance industry before joining the Group in 1999 as Clinical Manager. He established the Clinical Information, Advanced Analytics, Health Information Management and Clinical Services functions at Mediclinic, and subsequently served as the Mediclinic Group’s Chief Clinical Officer. He was appointed as an executive director of Mediclinic International Limited in 2010 up to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited. He was appointed as the Chief Executive Officer from 1 June 2018. He serves as a non-executive director of Spire Healthcare Group plc from 24 May 2018. Qualifications: Dr Van der Merwe holds a medical degree from the University of Stellenbosch (MB, Ch.B); a Diploma in Anaesthetics from the College of Anaesthetists of South Africa (DA (SA)); the Fellowship of the College of Anaesthetists of South Africa (FCA (SA)); and completed the Advanced Management Programme at Harvard Business School.

Jurgens Myburgh

Mr. Jurgens Myburgh is Chief Financial Officer, Executive Director of Mediclinic International Plc., since 1 August 2016. Prior to joining the Mediclinic Group, he served as Chief Financial Officer at Datatec Limited, an international information and communications technology group, which operates in over 60 countries, and before that, worked at The Standard Bank of South Africa Limited as Executive Vice President of Investment Banking. Qualifications: Mr Myburgh holds an Honours degree in Accounting from the University of Johannesburg (B.Comm. (Hons)); and is a qualified Chartered Accountant with the South African Institute of Chartered Accountants.

David Hadley

Mr. David Hadley is Chief Executive Officer - Mediclinic Middle East of the Company. He joined the Mediclinic Group in 1993, and worked in a variety of administrative roles in human resources, finance, operations and hospital management before being seconded to Dubai in 2007 to oversee the opening of Mediclinic City Hospital. He was appointed as the Chief Executive Officer of Mediclinic Middle East in 2009 and has served as a member of Mediclinic’s Executive Committee since 2011. Qualifications: Mr Hadley holds a Bachelor’s degree in Commerce from the University of South Africa; and a Master’s degree in Business Administration (with distinction) from the University of Liverpool.

Daniel Liedtke

Dr. Daniel Liedtke is Chief Executive Officer: Hirslanden of the Company. He joined Hirslanden Klinik St. Anna in 2001. He has held various clinical and managerial positions at Hirslanden prior to his appointment as Hospital Manager of Klinik Hirslanden in 2008, and was appointed as Chief Operating Officer of the Hirslanden Private Hospital Group in April 2015. He was appointed as the Chief Executive Officer of Hirslanden in 2019. Qualifications: Dr Liedtke is a qualified car electronic engineer (Diploma), Physiotherapist (B.Sc.) and Osteopath (D.O.). He holds a Master of Health Administration as well as a Doctor of Business Administration (Charles Sturt University).

Koert Pretorius

Mr. Koert Pretorius is Chief Executive Officer of Mediclinic Southern Africa of the Company. He joined the Group in 1998 as the regional manager of the central region of Mediclinic’s operations in South Africa, after which he was appointed as the Chief Operating Officer of the Mediclinic Group in 2003. He was appointed as the Chief Executive Officer of Mediclinic Southern Africa in 2008 and served as an executive director of Mediclinic International Limited in 2006 up to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited. Qualifications: Mr Pretorius holds a Bachelor’s degree in Accounting Science from the University of the Free State (B.Compt.); and a Master’s degree of Business Leadership from the University of South Africa (MBL).

Magnus Oetiker

Mr. Magnus Oetiker is Chief Human Resource Officer of the Company since February 2018. Prior to joining Mediclinic, he was the Chief Executive Officer of a family-owned company in Switzerland with 13 business units in healthcare and in the catering industry from 2016. Prior to that, he served in various management positions from 2000 to 2016 within the Hirslanden group, where he was appointed as a member of Hirslanden’s Executive Committee in 2008 and acted as Chief Strategy Officer, including Human Resources. Qualifications: Mr Oetiker holds a Bachelor of Science in Business Administration from the Zurich University of Applied Sciences, Switzerland; and an Executive Master of Business Administration from the University of Zurich, Switzerland.

Dirk Le Roux

Dr. Dirk Le Roux serves as Chief Information Officer of the Company. He joined Mediclinic in August 2014 as the Group ICT Executive. Prior to joining Mediclinic, he served in various managerial roles, including as managing director of ThinkWorx Consulting, Chief Information Officer at Media24, General Manager of IT Strategy and Risk at Absa Bank Limited, as well as the Head of IT at the Development Bank of Southern Africa. Qualifications: Dr Le Roux holds a D.Com. (Informatics) degree from the University of Pretoria; a Master’s degree in Business Administration (cum laude); a Postgraduate Diploma in Data Metrics; and a Bachelor’s degree in Civil Engineering.

Gert Hattingh

Mr. Gert Hattingh is Chief Corporate Services Officer of the Company. He joined the Mediclinic Group in 1991 as Group Accountant. He served in various management positions in the Group and was appointed as the company secretary in 2010 and Group Services Executive in 2011. Subsequent to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in February 2016, he no longer serves as the company secretary, but holds the position of Chief Corporate Services Officer. Qualifications: Mr Hattingh holds an Honours degree in Accountancy from the University of Stellenbosch (B.Acc. (Hons)); completed the Advanced Management Program at Harvard Business School; and is a qualified Chartered Accountant with the South African Institute of Chartered Accountants.

Rene Toua

Dr. Rene Toua is Chief Clinical Officer of the Company. She is a medical practitioner who worked extensively in the private as well as the public healthcare industry. She started her career in primary healthcare, established a geriatric private primary care practice and worked in emergency medicine, including an academic trauma unit, for several years. She joined Mediclinic in 2006 and held the positions of Regional Clinical Manager and Clinical Data and Information Manager for Mediclinic Southern Africa. Subsequently, she served as the Group General Manager: Clinical Performance. She also serves on the executive committee and board of trustees for Remedi, the in-house medical aid scheme, and is the chairperson of the medical advisory committee. She was appointed as the Chief Clinical Officer from 1 July 2018. Qualifications: Dr Toua holds a medical degree from the University of Stellenbosch (MB ChB); M Phil EM (Patient Safety and Clinical Decision Making) from the University of Cape Town and has completed a certificate in Project Management from the University of Stellenbosch Business School.

Jannie Durand

Mr. Jannie Jonathan (Jan) Durand is Non-Executive Director of Mediclinic International Plc., since 15 February 2016. Prior to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in 2016, he served as a non-executive director of Mediclinic International Limited from 2012. He joined the Rembrandt group in 1996 and was appointed as the Chief Executive Officer of Remgro Limited in 2012, which holds a 44.56% interest in the Company. In his current role, with more than 20 years’ experience in the investment industry, he acts as a non-executive director of various companies, including Distell Group Limited, FirstRand Limited, RCL Foods Limited and RMI Holdings Limited. Qualifications: Mr Durand holds an Honours degree in Accountancy from the University of Stellenbosch (B.Acc. (Hons)); a Master’s of Philosophy in Management Studies from Oxford University (M.Phil. (Management Studies)); and is a qualified Chartered Accountant with the South African Institute of Chartered Accountants. Mr Pieter Uys, the Head of Strategic Investment at Remgro Limited, is appointed as the alternate to Mr Durand since 7 April 2016. Prior to joining Remgro, Mr Uys was a founding member and ultimately became the Chief Executive Officer of the Vodacom group, one of the leading mobile networks in Africa. Qualifications: Mr Uys holds an M.Eng. (Electrical) degree; and an MBA from the University of Stellenbosch.

Danie Meintjes

Mr. Danie Meintjes is Non-Executive Director of the Company. He has served as the Chief Executive Officer of the Mediclinic Group from 2010 up to his retirement on 1 June 2018, remaining on the Board as an executive director until 31 July 2018 and currently serves as a non-executive director from 1 August 2018. He was appointed as an executive director and Chief Executive Officer of the Company on 15 February 2016. Prior to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in 2016, he served as the Chief Executive Officer of Mediclinic International Limited from 2010. He has served in various management positions in the Remgro group, before joining the Mediclinic Group in 1985 as the hospital manager of Mediclinic Sandton. He was appointed as a member of Mediclinic’s Executive Committee in 1995 and as a director in 1996. He was seconded to serve as a senior executive of the Group’s operations in Dubai in 2006, and appointed as the Chief Executive Officer of Mediclinic Middle East in 2007. He served as a non-executive director of Spire Healthcare Group plc from 2015, from which position he retired on 24 May 2018. Qualifications: Mr Meintjes holds an Honours degree in Industrial Psychology from the University of the Free State; and completed the Advanced Management Programme at Harvard Business School.

Trevor Petersen

Mr. Trevor David Petersen is Non-Executive Director of Mediclinic International Plc. He was appointed as an independent non-executive director of the Company on 15 February 2016. Prior to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in 2016, he served as an independent non-executive director of Mediclinic International Limited from 2012. In 1996, he resigned from the University of Cape Town to take up a partnership in the merged firm of PricewaterhouseCoopers Inc. He served as a partner of the national firm from 1997 to 2009 and served as the partner-in-charge of Cape Town and as Chairman of the Western Cape region. He is an independent non-executive director on the board of Media24 (Pty) Ltd (a subsidiary of Naspers Limited) and is currently the managing trustee of the Woodside Village Trust. He has served professional membership associations such as the South African Institute of Chartered Accountants, and was elected the Chairman of the National Body in 2006 and 2007. Qualifications: Mr Petersen holds an Honours degree in Accountancy from the University of Cape Town (B.Comm. (Hons)); and is a qualified Chartered Accountant with the South African Institute of Chartered Accountants.

Muhadditha Al Hashimi

Dr. Muhadditha Yahya Al Hashimi, Ph.D., is Independent Non-Executive Director of the Company since 1 November 2017. She is also a member of the board of trustees and the Audit and Compliance Committee of the University of Sharjah, and a member of the board of trustees of the UAE Nursing and Midwifery Council and the UAE Genetics Diseases Association. She is the campus director of Higher Colleges of Technology Sharjah Women's College in the UAE. Prior to her current positions, Dr Al Hashimi held the position of executive Dean of the Faculty of Health Sciences, Higher Colleges of Technology; acting deputy vice-chancellor of Academic Affairs at the Higher Colleges of Technology; Chief Executive Officer of the Mohammed Bin Rashid Al Maktoum Academic Medical Center in Dubai; Deputy Chief Executive Officer of Tatweer LLC; Chief Executive Officer of Dubai Healthcare City (both members of Dubai Holding); and a director of education of the Harvard Medical School Dubai Centre. Qualifications: Dr Al Hashimi obtained a Doctorate in Public Health from the University of Texas; a Master's degree in Clinical Laboratory Sciences from the University of Minnesota; and a Bachelor's degree in Medical Technology from the University of Minnesota.

James Grieve

Mr. James Alan Grieve was appointed Senior Non-Executive Independent Director of Mediclinic International Plc as of July 24, 2019. Prior to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in 2016, he served as an independent non-executive director of Mediclinic International Limited from 2012 and served as a director of Medi-Clinic Switzerland AG (now Hirslanden AG) from 2008 to 2012. He served as Chief Financial Offi cer of Reinet Investments Manager S.A. and Reinet Fund Manager S.A. from 2008 to 2011 and Chief Executive Offi cer from 2012 until he retired in 2014. He remains on the Board of both companies as a non-executive director. He served as Company Secretary of Richemont, the Swiss luxury goods group, from 1998 to 2004 and as Director of Corporate Aff airs from 2004 to 2014. Prior to joining Richemont’s predecessor companies in 1986, he worked with the international auditing fi rms now known as PricewaterhouseCoopers and Ernst & Young. Mr Grieve holds a degree in Business Administration from Heriot-Watt University, Edinburgh; and is a member of the Institute of Chartered Accountants of Scotland.

Felicity Harvey

Dr. Felicity A. H. Harvey, CBE, is Independent Non-Executive Director of Mediclinic International Plc., since 3 October 2017. She serves as a Visiting Professor at the Institute of Global Health Innovation at Imperial College London; is a non-executive director of Guy's and St Thomas' NHS Foundation Trust in London; a Trustee of Royal Trinity Hospice in London; and a member of the WHO Independent Oversight & Advisory Committee for Health Emergencies. Previously, she served as Director-General of Public and International Health at the UK Department of Health; Director of the UK Prime Minister's Delivery Unit, then HM Treasury’s Performance and Reform Unit; Head of the Medicines, Pharmacy and Industry Group at the Department of Health; Director of Prison Health at Her Majesty's Prison Service; Head of Quality Management at NHS Executive and private secretary to the Chief Medical Officer of the Department of Health of the United Kingdom. Dr Harvey was appointed CBE in 2008. Qualifications: Dr Harvey qualified in medicine in 1980; is an honorary fellow of the Royal College of Physicians; a fellow of the Faculty of Public Health; has an international MBA from Henley Management College; and has gained a Postgraduate Diploma in Clinical Microbiology at The Royal London Hospital College, University of London.

Seamus Declan Keating

Mr. Seamus Declan Keating is Independent Non-Executive Director of Mediclinic International Plc. He was appointed as an independent non-executive director of the Company (then Al Noor Hospitals Group plc) on 5 June 2013 and continues to serve as a director of the Company following the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in 2016. He has over 20 years’ experience in the global technology sector in finance and operational roles, and was a main board director of Logica plc from 2002 until April 2012. He was Chief Financial Officer of Logica plc from 2002 until 2010 when he became Chief Operating Officer and head of its Benelux operations. Prior to his role at Logica plc, he worked for the Olivetti Group in senior finance roles in the UK and Italy. He served as non-executive director and Chairman of the audit committee of Mouchel plc from November 2010 to September 2012. He is currently Chairman of First Derivatives plc, a non-executive director of BGL Group Limited, a non-executive director of Callcredit Information Group plc and a non-executive director of Mi-pay Group plc. Qualifications: Mr Keating is a fellow of the Chartered Institute of Management Accountants.

Anja Oswald

Dr. Anja Oswald is Independent Non-Executive Director of the Company 25 July 2018. She is the CEO of the Klinik Sonnenhalde, a well-established private clinic for psychiatry and psychotherapy with inpatients, day-care clinics and outpatients in Riehen, Switzerland and is Vice-President of the Association of Private Hospitals in Basel. Prior to this, she was Head of Medical and Pharmaceutical Services and Deputy Medical Officer in the Department of Health of the Cantonal Government in Basel and a member of various cantonal, regional and national committees. Dr Oswald was also CEO of a start-up company in the healthcare sector and worked several years as a Medical Doctor in different hospitals. Qualifications: Dr Oswald holds a Masters in Business Administration from the Rochester-Berne Executive MBA; a Doctorate in Medicine from the University of Basel specialising in orthopaedic surgery and traumatology as well as in sports medicine. She passed the Board School at the International Centre of Corporate Governance of the University of St. Gallen.

Tom Singer

Mr. Tom Singer serves as Non-Executive Independent Director of the Company with effect from 24 July 2019. He has extensive board experience and expertise in international branded consumer businesses and a thorough understanding of the UK listed environment. He has served as Chief Financial Officer of InterContinental Hotels Group PLC, a leading international hotel group, and British United Provident Association (BUPA), a provider of health insurance, care homes for the elderly and other health related services including private hospitals. Earlier in his career, Tom was Chief Financial Officer and Chief Operating Officer of William Hill PLC and Finance Director of Moss Bros PLC, having started his career in professional services spending a total of 12 years at Price Waterhouse and McKinsey. He currently serves as a non-executive director on the boards of DP Eurasia N.V., an operator of pizza restaurants in Turkey and Russia, and Liberty Living Group PLC, a provider of student accommodation in the UK. Tom holds a degree in Economics and Accounting (University of Bristol), is a Chartered Accountant and has attended the Advanced Management Programme at INSEAD.

James Arnold